COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis

R. Naveen; Ioannis Parodis; Mrudula Joshi; Parikshit Sen; Julius Lindblom; Vishwesh Agarwal; James B. Lilleker; Ai Lyn Tan; Arvind Nune; Samuel Katsuyuki Shinjo; Babur Salim; Nelly Ziade; Tsvetelina Velikova; Abraham Edgar Gracia-Ramos; Miguel A. Saavedra; Jessica Day; Ashima Makol; Oliver Distler; Hector Chinoy; Vikas Agarwal; Rohit Aggarwal; Latika Gupta; Elena Nikiphorou; Bhupen Barman; Yogesh Preet Singh; Rajiv Ranjan; Avinash Jain; Sapan C. Pandya; Rakesh Kumar Pilania; Aman Sharma; M. Manoj; Vikas Gupta; Chengappa G. Kavadichanda; Pradeepta Sekhar Patro; Sajal Ajmani; Sanat Phatak; Rudra Prosad Goswami; Abhra Chandra Chowdhury; Ashish Jacob Mathew; Padnamabha Shenoy; Ajay Asranna; Keerthi Talari Bommakanti; Anuj Shukla; Arun Kumar R. Pandey; Kunal Chandwar; Sinan Kardeş; Döndü Üsküdar Cansu; Minchul Kim; Ashima Makol; Tulika Chatterjee; John D. Pauling; Chris Wincup; Lorenzo Cavagna; Nicoletta Del Papa; Gianluca Sambataro; Atzeni Fabiola; Marcello Govoni; Simone Parisi; Elena Bartoloni Bocci; Gian Domenico Sebastiani; Enrico Fusaro; Marco Sebastiani; Luca Quartuccio; Franco Franceschini; Pier Paolo Sainaghi; Giovanni Orsolini; Rossella De Angelis; Maria Giovanna Danielli; Vincenzo Venerito; Dr Marcin Milchert; Lisa S. Traboco; Suryo Anggoro Kusumo Wibowo; Erick Adrian Zamora Tehozol; Jorge Rojas Serrano; Ignacio García De La Torre; Jesús Loarce-Martos; Sergio Prieto-González; Albert Gil-Vila; Raquel Aranega Gonzalez; Masataka Kuwana; Akira Yoshida; Ran Nakashima; Shinji Sato; Naoki Kimura; Yuko Kaneko; Johannes Knitza; Stylianos Tomaras; Margarita Aleksandrovna Gromova; Or Aharonov; Tamer A. Gheita; Ihsane Hmamouchi; Leonardo Santos Hoff; Margherita Giannini; François Maurier; Julien Campagne; Alain Meyer; Melinda Nagy-Vincze; Daman Langguth; Vidya Limaye; Merrilee Needham; Nilesh Srivastav; Marie Hudson; Oceane Landon-Cardinal; Syahrul Sazliyana Shaharir; Wilmer Gerardo Rojas Zuleta; Jose António Pereira Silva; João Eurico Fonseca; Olena Zimba

doi:10.1093/rheumatology/keac624

COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis

R. Naveen, Ioannis Parodis, Mrudula Joshi, Parikshit Sen, Julius Lindblom, Vishwesh Agarwal, James B. Lilleker, Ai Lyn Tan, Arvind Nune, Samuel Katsuyuki Shinjo, Babur Salim, Nelly Ziade, Tsvetelina Velikova, Abraham Edgar Gracia-Ramos, Miguel A. Saavedra, Jessica Day, Ashima Makol, Oliver Distler, Hector Chinoy, Vikas AgarwalRohit Aggarwal, Latika Gupta, Elena Nikiphorou, Bhupen Barman, Yogesh Preet Singh, Rajiv Ranjan, Avinash Jain, Sapan C. Pandya, Rakesh Kumar Pilania, Aman Sharma, M. Manoj, Vikas Gupta, Chengappa G. Kavadichanda, Pradeepta Sekhar Patro, Sajal Ajmani, Sanat Phatak, Rudra Prosad Goswami, Abhra Chandra Chowdhury, Ashish Jacob Mathew, Padnamabha Shenoy, Ajay Asranna, Keerthi Talari Bommakanti, Anuj Shukla, Arun Kumar R. Pandey, Kunal Chandwar, Sinan Kardeş, Döndü Üsküdar Cansu, Minchul Kim, Ashima Makol, Tulika Chatterjee, John D. Pauling, Chris Wincup, Lorenzo Cavagna, Nicoletta Del Papa, Gianluca Sambataro, Atzeni Fabiola, Marcello Govoni, Simone Parisi, Elena Bartoloni Bocci, Gian Domenico Sebastiani, Enrico Fusaro, Marco Sebastiani, Luca Quartuccio, Franco Franceschini, Pier Paolo Sainaghi, Giovanni Orsolini, Rossella De Angelis, Maria Giovanna Danielli, Vincenzo Venerito, Dr Marcin Milchert, Lisa S. Traboco, Suryo Anggoro Kusumo Wibowo, Erick Adrian Zamora Tehozol, Jorge Rojas Serrano, Ignacio García De La Torre, Jesús Loarce-Martos, Sergio Prieto-González, Albert Gil-Vila, Raquel Aranega Gonzalez, Masataka Kuwana, Akira Yoshida, Ran Nakashima, Shinji Sato, Naoki Kimura, Yuko Kaneko, Johannes Knitza, Stylianos Tomaras, Margarita Aleksandrovna Gromova, Or Aharonov, Tamer A. Gheita, Ihsane Hmamouchi, Leonardo Santos Hoff, Margherita Giannini, François Maurier, Julien Campagne, Alain Meyer, Melinda Nagy-Vincze, Daman Langguth, Vidya Limaye, Merrilee Needham, Nilesh Srivastav, Marie Hudson, Oceane Landon-Cardinal, Syahrul Sazliyana Shaharir, Wilmer Gerardo Rojas Zuleta, Jose António Pereira Silva, João Eurico Fonseca, Olena Zimba

Rheumatology

Research output: Contribution to journal › Article › peer-review

Abstract

Objectives: The COVID-19 vaccination in autoimmune diseases (COVAD) study aimed to assess short-term COVID-19 vaccination-related adverse events (AEs) in RA patients. Methods: An online self-reported questionnaire (March-December 2021) was used to capture data related to COVID-19 vaccination-related AEs in RA, other autoimmune rheumatic diseases (AIRDs) (excluding RA and inflammatory myositis), non-rheumatic autoimmune diseases (nrAIDs) and healthy controls (HCs). Descriptive and multivariable regression analyses were performed. Results: Of the 9462 complete respondents, 14.2% (n = 1347) had been diagnosed with RA; they had a mean (s.d.) age of 50.7 (13.7) years, 74.2% were women and 49.3% were Caucasian. In total, 76.9% and 4.2% of patients with RA reported minor and major AEs, respectively. Patients with active and inactive RA had similar AE and hospitalization frequencies. Overall, AEs were reported more frequently by BNT162b2 and mRNA-1273 recipients and less frequently by BBV152 recipients compared with the rest. Major AE and hospitalization frequencies were similar across recipients of different vaccines. Patients receiving methotrexate and hydroxychloroquine reported fewer minor AEs than those patients not on them. Compared with HCs and patients with other AIRDs, patients with RA reported similar total AEs, overall minor AEs, and hospitalizations. Compared with nrAIDs, patients with RA reported lower frequencies of overall AEs, minor AEs (both odds ratio [OR] = 0.7; 95% CI: 0.5, 0.9), and injection site pain (OR = 0.6; 95% CI: 0.5, 0.8) with similar major AE and hospitalization frequencies. Conclusion: Despite the differences in AE frequency across different COVID-19 vaccines, all were well tolerated in patients with RA and were comparable to HCs, providing reassurance as to the safety of COVID-19 vaccination.

Original language	English (US)
Pages (from-to)	2366-2376
Number of pages	11
Journal	Rheumatology (United Kingdom)
Volume	62
Issue number	7
DOIs	https://doi.org/10.1093/rheumatology/keac624
State	Published - Jul 1 2023

Keywords

Adverse effects
COVID-19
RA
autoimmune diseases
vaccination

ASJC Scopus subject areas

Rheumatology
Pharmacology (medical)

Access to Document

10.1093/rheumatology/keac624

Cite this

Naveen, R., Parodis, I., Joshi, M., Sen, P., Lindblom, J., Agarwal, V., Lilleker, J. B., Tan, A. L., Nune, A., Shinjo, S. K., Salim, B., Ziade, N., Velikova, T., Edgar Gracia-Ramos, A., Saavedra, M. A., Day, J., Makol, A., Distler, O., Chinoy, H., ... Zimba, O. (2023). COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis. Rheumatology (United Kingdom), 62(7), 2366-2376. https://doi.org/10.1093/rheumatology/keac624

Naveen, R, Parodis, I, Joshi, M, Sen, P, Lindblom, J, Agarwal, V, Lilleker, JB, Tan, AL, Nune, A, Shinjo, SK, Salim, B, Ziade, N, Velikova, T, Edgar Gracia-Ramos, A, Saavedra, MA, Day, J, Makol, A, Distler, O, Chinoy, H, Agarwal, V, Aggarwal, R, Gupta, L, Nikiphorou, E, Barman, B, Singh, YP, Ranjan, R, Jain, A, Pandya, SC, Pilania, RK, Sharma, A, Manoj, M, Gupta, V, Kavadichanda, CG, Patro, PS, Ajmani, S, Phatak, S, Goswami, RP, Chowdhury, AC, Mathew, AJ, Shenoy, P, Asranna, A, Bommakanti, KT, Shukla, A, Pandey, AKR, Chandwar, K, Kardeş, S, Cansu, DÜ, Kim, M, Makol, A, Chatterjee, T, Pauling, JD, Wincup, C, Cavagna, L, Del Papa, N, Sambataro, G, Fabiola, A, Govoni, M, Parisi, S, Bocci, EB, Sebastiani, GD, Fusaro, E, Sebastiani, M, Quartuccio, L, Franceschini, F, Sainaghi, PP, Orsolini, G, De Angelis, R, Danielli, MG, Venerito, V, Milchert, DM, Traboco, LS, Wibowo, SAK, Tehozol, EAZ, Serrano, JR, De La Torre, IG, Loarce-Martos, J, Prieto-González, S, Gil-Vila, A, Gonzalez, RA, Kuwana, M, Yoshida, A, Nakashima, R, Sato, S, Kimura, N, Kaneko, Y, Knitza, J, Tomaras, S, Gromova, MA, Aharonov, O, Gheita, TA, Hmamouchi, I, Hoff, LS, Giannini, M, Maurier, F, Campagne, J, Meyer, A, Nagy-Vincze, M, Langguth, D, Limaye, V, Needham, M, Srivastav, N, Hudson, M, Landon-Cardinal, O, Shaharir, SS, Zuleta, WGR, Silva, JAP, Fonseca, JE & Zimba, O 2023, 'COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis', Rheumatology (United Kingdom), vol. 62, no. 7, pp. 2366-2376. https://doi.org/10.1093/rheumatology/keac624

@article{5e00091c1f95457cbecb8f21806be473,

title = "COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis",

abstract = "Objectives: The COVID-19 vaccination in autoimmune diseases (COVAD) study aimed to assess short-term COVID-19 vaccination-related adverse events (AEs) in RA patients. Methods: An online self-reported questionnaire (March-December 2021) was used to capture data related to COVID-19 vaccination-related AEs in RA, other autoimmune rheumatic diseases (AIRDs) (excluding RA and inflammatory myositis), non-rheumatic autoimmune diseases (nrAIDs) and healthy controls (HCs). Descriptive and multivariable regression analyses were performed. Results: Of the 9462 complete respondents, 14.2% (n = 1347) had been diagnosed with RA; they had a mean (s.d.) age of 50.7 (13.7) years, 74.2% were women and 49.3% were Caucasian. In total, 76.9% and 4.2% of patients with RA reported minor and major AEs, respectively. Patients with active and inactive RA had similar AE and hospitalization frequencies. Overall, AEs were reported more frequently by BNT162b2 and mRNA-1273 recipients and less frequently by BBV152 recipients compared with the rest. Major AE and hospitalization frequencies were similar across recipients of different vaccines. Patients receiving methotrexate and hydroxychloroquine reported fewer minor AEs than those patients not on them. Compared with HCs and patients with other AIRDs, patients with RA reported similar total AEs, overall minor AEs, and hospitalizations. Compared with nrAIDs, patients with RA reported lower frequencies of overall AEs, minor AEs (both odds ratio [OR] = 0.7; 95% CI: 0.5, 0.9), and injection site pain (OR = 0.6; 95% CI: 0.5, 0.8) with similar major AE and hospitalization frequencies. Conclusion: Despite the differences in AE frequency across different COVID-19 vaccines, all were well tolerated in patients with RA and were comparable to HCs, providing reassurance as to the safety of COVID-19 vaccination.",

keywords = "Adverse effects, COVID-19, RA, autoimmune diseases, vaccination",

author = "R. Naveen and Ioannis Parodis and Mrudula Joshi and Parikshit Sen and Julius Lindblom and Vishwesh Agarwal and Lilleker, {James B.} and Tan, {Ai Lyn} and Arvind Nune and Shinjo, {Samuel Katsuyuki} and Babur Salim and Nelly Ziade and Tsvetelina Velikova and {Edgar Gracia-Ramos}, Abraham and Saavedra, {Miguel A.} and Jessica Day and Ashima Makol and Oliver Distler and Hector Chinoy and Vikas Agarwal and Rohit Aggarwal and Latika Gupta and Elena Nikiphorou and Bhupen Barman and Singh, {Yogesh Preet} and Rajiv Ranjan and Avinash Jain and Pandya, {Sapan C.} and Pilania, {Rakesh Kumar} and Aman Sharma and M. Manoj and Vikas Gupta and Kavadichanda, {Chengappa G.} and Patro, {Pradeepta Sekhar} and Sajal Ajmani and Sanat Phatak and Goswami, {Rudra Prosad} and Chowdhury, {Abhra Chandra} and Mathew, {Ashish Jacob} and Padnamabha Shenoy and Ajay Asranna and Bommakanti, {Keerthi Talari} and Anuj Shukla and Pandey, {Arun Kumar R.} and Kunal Chandwar and Sinan Karde{\c s} and Cansu, {D{\"o}nd{\"u} {\"U}sk{\"u}dar} and Minchul Kim and Ashima Makol and Tulika Chatterjee and Pauling, {John D.} and Chris Wincup and Lorenzo Cavagna and {Del Papa}, Nicoletta and Gianluca Sambataro and Atzeni Fabiola and Marcello Govoni and Simone Parisi and Bocci, {Elena Bartoloni} and Sebastiani, {Gian Domenico} and Enrico Fusaro and Marco Sebastiani and Luca Quartuccio and Franco Franceschini and Sainaghi, {Pier Paolo} and Giovanni Orsolini and {De Angelis}, Rossella and Danielli, {Maria Giovanna} and Vincenzo Venerito and Milchert, {Dr Marcin} and Traboco, {Lisa S.} and Wibowo, {Suryo Anggoro Kusumo} and Tehozol, {Erick Adrian Zamora} and Serrano, {Jorge Rojas} and {De La Torre}, {Ignacio Garc{\'i}a} and Jes{\'u}s Loarce-Martos and Sergio Prieto-Gonz{\'a}lez and Albert Gil-Vila and Gonzalez, {Raquel Aranega} and Masataka Kuwana and Akira Yoshida and Ran Nakashima and Shinji Sato and Naoki Kimura and Yuko Kaneko and Johannes Knitza and Stylianos Tomaras and Gromova, {Margarita Aleksandrovna} and Or Aharonov and Gheita, {Tamer A.} and Ihsane Hmamouchi and Hoff, {Leonardo Santos} and Margherita Giannini and Fran{\c c}ois Maurier and Julien Campagne and Alain Meyer and Melinda Nagy-Vincze and Daman Langguth and Vidya Limaye and Merrilee Needham and Nilesh Srivastav and Marie Hudson and Oceane Landon-Cardinal and Shaharir, {Syahrul Sazliyana} and Zuleta, {Wilmer Gerardo Rojas} and Silva, {Jose Ant{\'o}nio Pereira} and Fonseca, {Jo{\~a}o Eurico} and Olena Zimba",

year = "2023",

month = jul,

day = "1",

doi = "10.1093/rheumatology/keac624",

language = "English (US)",

volume = "62",

pages = "2366--2376",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - COVID-19 vaccination in autoimmune diseases (COVAD) study

T2 - Vaccine safety and tolerance in rheumatoid arthritis

AU - Naveen, R.

AU - Parodis, Ioannis

AU - Joshi, Mrudula

AU - Sen, Parikshit

AU - Lindblom, Julius

AU - Agarwal, Vishwesh

AU - Lilleker, James B.

AU - Tan, Ai Lyn

AU - Nune, Arvind

AU - Shinjo, Samuel Katsuyuki

AU - Salim, Babur

AU - Ziade, Nelly

AU - Velikova, Tsvetelina

AU - Edgar Gracia-Ramos, Abraham

AU - Saavedra, Miguel A.

AU - Day, Jessica

AU - Makol, Ashima

AU - Distler, Oliver

AU - Chinoy, Hector

AU - Agarwal, Vikas

AU - Aggarwal, Rohit

AU - Gupta, Latika

AU - Nikiphorou, Elena

AU - Barman, Bhupen

AU - Singh, Yogesh Preet

AU - Ranjan, Rajiv

AU - Jain, Avinash

AU - Pandya, Sapan C.

AU - Pilania, Rakesh Kumar

AU - Sharma, Aman

AU - Manoj, M.

AU - Gupta, Vikas

AU - Kavadichanda, Chengappa G.

AU - Patro, Pradeepta Sekhar

AU - Ajmani, Sajal

AU - Phatak, Sanat

AU - Goswami, Rudra Prosad

AU - Chowdhury, Abhra Chandra

AU - Mathew, Ashish Jacob

AU - Shenoy, Padnamabha

AU - Asranna, Ajay

AU - Bommakanti, Keerthi Talari

AU - Shukla, Anuj

AU - Pandey, Arun Kumar R.

AU - Chandwar, Kunal

AU - Kardeş, Sinan

AU - Cansu, Döndü Üsküdar

AU - Kim, Minchul

AU - Makol, Ashima

AU - Chatterjee, Tulika

AU - Pauling, John D.

AU - Wincup, Chris

AU - Cavagna, Lorenzo

AU - Del Papa, Nicoletta

AU - Sambataro, Gianluca

AU - Fabiola, Atzeni

AU - Govoni, Marcello

AU - Parisi, Simone

AU - Bocci, Elena Bartoloni

AU - Sebastiani, Gian Domenico

AU - Fusaro, Enrico

AU - Sebastiani, Marco

AU - Quartuccio, Luca

AU - Franceschini, Franco

AU - Sainaghi, Pier Paolo

AU - Orsolini, Giovanni

AU - De Angelis, Rossella

AU - Danielli, Maria Giovanna

AU - Venerito, Vincenzo

AU - Milchert, Dr Marcin

AU - Traboco, Lisa S.

AU - Wibowo, Suryo Anggoro Kusumo

AU - Tehozol, Erick Adrian Zamora

AU - Serrano, Jorge Rojas

AU - De La Torre, Ignacio García

AU - Loarce-Martos, Jesús

AU - Prieto-González, Sergio

AU - Gil-Vila, Albert

AU - Gonzalez, Raquel Aranega

AU - Kuwana, Masataka

AU - Yoshida, Akira

AU - Nakashima, Ran

AU - Sato, Shinji

AU - Kimura, Naoki

AU - Kaneko, Yuko

AU - Knitza, Johannes

AU - Tomaras, Stylianos

AU - Gromova, Margarita Aleksandrovna

AU - Aharonov, Or

AU - Gheita, Tamer A.

AU - Hmamouchi, Ihsane

AU - Hoff, Leonardo Santos

AU - Giannini, Margherita

AU - Maurier, François

AU - Campagne, Julien

AU - Meyer, Alain

AU - Nagy-Vincze, Melinda

AU - Langguth, Daman

AU - Limaye, Vidya

AU - Needham, Merrilee

AU - Srivastav, Nilesh

AU - Hudson, Marie

AU - Landon-Cardinal, Oceane

AU - Shaharir, Syahrul Sazliyana

AU - Zuleta, Wilmer Gerardo Rojas

AU - Silva, Jose António Pereira

AU - Fonseca, João Eurico

AU - Zimba, Olena

PY - 2023/7/1

Y1 - 2023/7/1

N2 - Objectives: The COVID-19 vaccination in autoimmune diseases (COVAD) study aimed to assess short-term COVID-19 vaccination-related adverse events (AEs) in RA patients. Methods: An online self-reported questionnaire (March-December 2021) was used to capture data related to COVID-19 vaccination-related AEs in RA, other autoimmune rheumatic diseases (AIRDs) (excluding RA and inflammatory myositis), non-rheumatic autoimmune diseases (nrAIDs) and healthy controls (HCs). Descriptive and multivariable regression analyses were performed. Results: Of the 9462 complete respondents, 14.2% (n = 1347) had been diagnosed with RA; they had a mean (s.d.) age of 50.7 (13.7) years, 74.2% were women and 49.3% were Caucasian. In total, 76.9% and 4.2% of patients with RA reported minor and major AEs, respectively. Patients with active and inactive RA had similar AE and hospitalization frequencies. Overall, AEs were reported more frequently by BNT162b2 and mRNA-1273 recipients and less frequently by BBV152 recipients compared with the rest. Major AE and hospitalization frequencies were similar across recipients of different vaccines. Patients receiving methotrexate and hydroxychloroquine reported fewer minor AEs than those patients not on them. Compared with HCs and patients with other AIRDs, patients with RA reported similar total AEs, overall minor AEs, and hospitalizations. Compared with nrAIDs, patients with RA reported lower frequencies of overall AEs, minor AEs (both odds ratio [OR] = 0.7; 95% CI: 0.5, 0.9), and injection site pain (OR = 0.6; 95% CI: 0.5, 0.8) with similar major AE and hospitalization frequencies. Conclusion: Despite the differences in AE frequency across different COVID-19 vaccines, all were well tolerated in patients with RA and were comparable to HCs, providing reassurance as to the safety of COVID-19 vaccination.

AB - Objectives: The COVID-19 vaccination in autoimmune diseases (COVAD) study aimed to assess short-term COVID-19 vaccination-related adverse events (AEs) in RA patients. Methods: An online self-reported questionnaire (March-December 2021) was used to capture data related to COVID-19 vaccination-related AEs in RA, other autoimmune rheumatic diseases (AIRDs) (excluding RA and inflammatory myositis), non-rheumatic autoimmune diseases (nrAIDs) and healthy controls (HCs). Descriptive and multivariable regression analyses were performed. Results: Of the 9462 complete respondents, 14.2% (n = 1347) had been diagnosed with RA; they had a mean (s.d.) age of 50.7 (13.7) years, 74.2% were women and 49.3% were Caucasian. In total, 76.9% and 4.2% of patients with RA reported minor and major AEs, respectively. Patients with active and inactive RA had similar AE and hospitalization frequencies. Overall, AEs were reported more frequently by BNT162b2 and mRNA-1273 recipients and less frequently by BBV152 recipients compared with the rest. Major AE and hospitalization frequencies were similar across recipients of different vaccines. Patients receiving methotrexate and hydroxychloroquine reported fewer minor AEs than those patients not on them. Compared with HCs and patients with other AIRDs, patients with RA reported similar total AEs, overall minor AEs, and hospitalizations. Compared with nrAIDs, patients with RA reported lower frequencies of overall AEs, minor AEs (both odds ratio [OR] = 0.7; 95% CI: 0.5, 0.9), and injection site pain (OR = 0.6; 95% CI: 0.5, 0.8) with similar major AE and hospitalization frequencies. Conclusion: Despite the differences in AE frequency across different COVID-19 vaccines, all were well tolerated in patients with RA and were comparable to HCs, providing reassurance as to the safety of COVID-19 vaccination.

KW - Adverse effects

KW - COVID-19

KW - RA

KW - autoimmune diseases

KW - vaccination

UR - http://www.scopus.com/inward/record.url?scp=85149134170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149134170&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/keac624

DO - 10.1093/rheumatology/keac624

M3 - Article

C2 - 36315075

AN - SCOPUS:85149134170

SN - 1462-0324

VL - 62

SP - 2366

EP - 2376

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 7

ER -

COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this